Apollo Hospitals Enterprise’s (AHEL) Q3FY23 performance was a miss vs our estimates. Revenue grew 17.2% YoY to Rs42.6bn led by strong growth in pharmacy business (I-Sec: Rs43.5bn). EBITDA margin was down 140bps QoQ at 11.9%, with higher spend on Apollo 24x7.